CPA 926
CPA 926 is a prodrug of Esculetin (HY-N0284) and is orally active. CPA 926 can inhibit the production of MMP in cartilage explants. CPA 926 can be used for the research of inflammation, such as experimental osteoarthritis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 169673-60-3
- Fòrmula: C17H19NO9
- Peso molecular:381.33
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 169673-60-3
-
Peso molecular 381.33
-
Fòrmula C17H19NO9
-
SMILES
OC1=C(C=C2C(OC(C=C2)=O)=C1)O[C@H]3[C@@H]([C@H]([C@H](O)[C@@H](CO)O3)O)NC(C)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Yamada H, et al. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis. J Rheumatol. 1999 Mar;26(3):654-62. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)